SCHEMBL15545367

SCHEMBL15545367

COS(=O)(=O)[O-].C[N+]1(C)CCN(c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])CC1

nearest known ligand 0.57

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
GAA P10253 3/20 0.56
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 2/20 0.47
LMNA P02545 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 1/20 0.45
RECQL P46063 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15586120 0.90 GAA (0.68) MAPTGAATDP1ALDH1A1KDM4E
SCHEMBL5357980 0.81 SIRT6 (0.52) MAPTALDH1A1LMNASMN1; SMN2POLB
SCHEMBL14785080 0.81 MAPT (0.54) MAPTGAATDP1ALDH1A1LMNA
SCHEMBL16755433 0.81 MAPT (0.42) MAPTTDP1ALDH1A1LMNASMN1; SMN2
SCHEMBL9938525 0.79 ALDH1A1 (0.58) MAPTALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL7517180 0.77 GAA (0.84) MAPTGAATDP1ALDH1A1KDM4E
SCHEMBL9396792 0.77 GAA (0.84) MAPTGAATDP1ALDH1A1KDM4E
SCHEMBL15568163 0.77 KDM4E (0.48) MAPTGAATDP1ALDH1A1KDM4E
SCHEMBL5393424 0.77 MAPT (0.54) MAPTALDH1A1LMNASMN1; SMN2MAPK1
SCHEMBL7807230 0.74 GAA (0.97) MAPTGAATDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9345653-B2 Dye composition comprising a cationic meta-phenylenediamine L'OREAL (FR) 2016-05-24 US disclosed
US-20150143638-A1 DYE COMPOSITION COMPRISING A CATIONIC META-PHENYLENEDIAMINE L'OREAL (FR) 2015-05-28 US disclosed
EP-2867212-A1 DYE COMPOSITION COMPRISING A CATIONIC META-PHENYLENEDIAMINE L'Oréal (FR) 2015-05-06 EP disclosed
WO-2014005900-A1 DYE COMPOSITION COMPRISING A CATIONIC META-PHENYLENEDIAMINE L'OREAL (FR) 2014-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150143638-A1 DYE COMPOSITION COMPRISING A CATIONIC META-PHENYLENEDIAMINE TYR, MAOA, CUTA MAPT 3769/4885GAA 2533/4885TDP1 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.